Journal of Commercial Biotechnology
Công bố khoa học tiêu biểu
* Dữ liệu chỉ mang tính chất tham khảo
Sắp xếp:
Hoạt động thương mại hóa và thành lập công ty khởi nghiệp của Viện Công nghệ Sinh học Dịch bởi AI
Journal of Commercial Biotechnology - Tập 11 - Trang 305-317 - 2005
Kiến thức hiện nay được công nhận là động lực chính cho đổi mới, năng suất và tăng trưởng kinh tế. Các nền kinh tế mới sẽ cần đầu tư mạnh mẽ vào nghiên cứu và phát triển, giáo dục và đào tạo, cũng như phát triển các mối quan hệ và dòng chảy mới giữa các bên liên quan chính, bao gồm chính phủ, học viện và ngành công nghiệp. Lĩnh vực giáo dục đại học sẽ đóng vai trò chủ chốt trong việc cung cấp nhữn......
#công nghệ sinh học #thương mại hóa #công ty khởi nghiệp #nghiên cứu và phát triển #giáo dục đại học
Spin-out fever: Spinning out a University of Oxford company and comments on the process in other universities
Journal of Commercial Biotechnology - Tập 12 - Trang 213-219 - 2006
University spin-out companies are increasing seen as a favoured route for commercialisation of university intellectual property. There has been criticism in the Lambert Review of Business–University Collaboration in 2003, commissioned by the UK Government in 2003, that there have been too many spin-outs of low quality and that a measure of quality is the amount of external equity they attract. Thi......
Building the future biotechnology workforce: A University of Houston model
Journal of Commercial Biotechnology - Tập 15 - Trang 171-182 - 2009
The field of biotechnology has become more quantitative and interdisciplinary as research in biotechnology continues to grow at a tremendous rate with broader and complex applications in medicine, agriculture, the environment and nanobiotechnology. The tremendous research in recombinant DNA technology has profoundly transformed the way biologists design, perform and analyze experiments. As biologi......
Pricing biologics: Issues, strategic priorities and a conceptual model
Journal of Commercial Biotechnology - Tập 17 - Trang 7-23 - 2010
The advent of complex and often expensive biologics raises critical commercial challenges – the most important of which pertains to developing a viable pricing, distribution and reimbursement model that is intrinsically geared to the special characteristics of biologic products and the expectations of a diverse customer population. Idiosyncratic differences in health-care systems, their philosophi......
The impact of pharmacogenetics and pharmacogenomics
Journal of Commercial Biotechnology - Tập 10 - Trang 60-77 - 2003
Pharmacogenetics is widely proclaimed as about to revolutionise the face of medicine. In a more realistic assessment, the implementation of molecular genetics and biology will continue to provide, as it has done already, better ways to diagnose and treat illnesses, but it will do so at a steady and evolutionary pace based on an improved understanding of the nature of disease, allowing more specifi......
Biotechnology and pharmaceutical R&D and licensing trends: You pays your money and takes your chances
Journal of Commercial Biotechnology - Tập 10 - Trang 54-59 - 2003
R&D costs in the biotechnology and pharmaceutical industries continue to rocket, as do royalty rates for the relatively few new drugs and technology that successfully complete clinical testing. Several of the issues that led to last year's joint Department of Justice/Federal Trade Commission (DOJ/FTC) hearings are significant within those industries, including (1) recent court decisions reaching i......
Teaming in biotechnology commercialisation: The diversity-performance connection and how university programmes can make a difference
Journal of Commercial Biotechnology - Tập 15 - Trang 3-11 - 2008
Collaboration across disciplines in the sciences is on the rise. Yet, practitioner papers abound that describe a range of dysfunctional team experiences, especially in contexts where science and business intersect. A critical issue currently preventing successful bioscience commercialisation is management's lack of ‘soft skills,’ such as the ability to direct complex and functionally diverse teams......
Editorial: Yin, yang and the biopharmaceutical industry
Journal of Commercial Biotechnology - Tập 9 Số 4 - Trang 283-285 - 2003
Tổng số: 259
- 1
- 2
- 3
- 4
- 5
- 6
- 10